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Abstract
The aging process affects every tissue in the body and represents one of the most complicated and highly integrated
inevitable physiological entities. The maintenance of good health during the aging process likely relies upon the coherent
regulation of hormonal and neuronal communication between the central nervous system and the periphery. Evidence has
demonstrated that the optimal regulation of energy usage in both these systems facilitates healthy aging. However, the
proteomic effects of aging in regions of the brain vital for integrating energy balance and neuronal activity are not well
understood. The hypothalamus is one of the main structures in the body responsible for sustaining an efficient interaction
between energy balance and neurological activity. Therefore, a greater understanding of the effects of aging in the
hypothalamus may reveal important aspects of overall organismal aging and may potentially reveal the most crucial protein
factors supporting this vital signaling integration. In this study, we examined alterations in protein expression in the
hypothalami of young, middle-aged, and old rats. Using novel combinatorial bioinformatics analyses, we were able to gain
a better understanding of the proteomic and phenotypic changes that occur during the aging process and have potentially
identified the G protein-coupled receptor/cytoskeletal-associated protein GIT2 as a vital integrator and modulator of the
normal aging process.
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Introduction
The aging process is associated with an accumulation of
molecular perturbations and potential damage to the body’s cells,
tissues, and organs. These alterations affect multiple processes
related to cell survival, genomic instability, altered gene expression
patterns, aberrant cellular replication, oxidative damage by
reactive oxygen species (ROS), and fluctuations in protein
expression and coherent protein post-translational modification
[1]. Therefore, with old age and a reduced ability to cope with
stress, the body becomes more prone to a variety of pathophy-
siologies such as neurodegeneration and metabolic syndrome.
These accumulated and progressive changes in complex physio-
logical systems such as the endocrine or central nervous system
(CNS) are highly likely to be mediated by entire networks of genes
and proteins rather than just one single factor. Considerable
evidence suggests that both neurodegenerative diseases and
pathophysiological aging processes involve a functional interplay
between a series of diverse biological systems including neurolog-
ical, endocrinological, sensory, and metabolic activities [2–7].
Many of these systems are functionally integrated together in one
crucial organ – the hypothalamus. The hypothalamus is re-
sponsible for the regulation of many metabolic pathways by
synthesizing and secreting numerous neurohormones that stimu-
late or inhibit the secretion of trophic hormones from the anterior
pituitary. The hypothalamus therefore can control body temper-
ature, thirst, hunger, fatigue, and circadian rhythms [8]. Not only
does the hypothalamus act as a master trophic controller of the
endocrine system, but it also possesses neuronal projections to
many autonomous and higher centers of the brain [9].
As the hypothalamus forms a vital link between multiple
complex physiological systems, its role in maintaining the fidelity
of ‘neurometabolic’ trans-network communication during the
normal or pathological aging process may be of paramount
importance for gerontological scientists. In addition, by manipu-
lating certain neuroendocrine hormones to selectively modulate
hypothalamic functioning, it may be possible in the future to
therapeutically regulate the aging process. For example, regulation
of insulin/IGF-1 signaling, a system that strongly regulates
hypothalamic function, increased the lifespan of the model
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dopa, which elevate hypothalamic catecholamine activity, have
been shown to increase the lifespan of mice by approximately 50%
[12].
The emerging appreciation of the coherent connectivity
between multiple physiological systems has generated the need
to develop a ‘higher-order’ level of understanding of the
integration of these systems, i.e., so-called ‘systems biology’. This
concept of network or ‘systems’ biology, i.e. biological functions are
mediated by strongly or weakly connected groups of genes/
proteins rather than simple linear signaling pathways, can often
seem too diffuse and non-specific to yield actionable data for
biomedical or pharmaceutical science. Recent mathematical
modeling of ‘real-world’ networks have demonstrated that, in
most cases, complex network systems are not connected in
a equitable and homogenous manner, but rather typically consist
of at least two levels, i.e., small, tightly-connected ‘sub-networks’
which are then collected together into larger constellations of
groups of multiple ‘sub-networks’ [13]. From a biological stand-
point, it is easy to analogize the small ‘sub-networks’ to biological
programs such as kinase signaling cascades (e.g. mitogen-activated
protein kinase cascades) or receptor signaling systems (e.g. insulin
receptor signaling system) in different tissues, while endocrine or
neuronal axes could represent the constellations of these groups of
smaller ‘sub-networks’.
While the physiological output of any given gene/protein
network may be an eventual function of the activity of all of the
constituent components, the relative contribution (to the eventual
functional output) of each gene/protein in this network is not
equal [14,15]. Hence within networks of functionally-related
genes/proteins, there are likely to exist specific hubs that consist of
genes/proteins that form the most important bridges, or ‘loose-
connections’, between the smaller functional programs (‘sub-
networks’) contained within the global network system. Such
genes/proteins within a functional network are often described as
keystones. These keystones profoundly enhance and facilitate
rapid and facile connection between disparate parts of a network
constellation and, as such, can be considered as functional ‘short-
cuts’ in the complex system [13]. It has been demonstrated, using
mathematical modeling of graph and network theories, that even
in networks containing thousands to millions of nodes, surprisingly
few (5–10) ‘short-cuts’ (keystones) are required to facilitate rapid
transfer across even the largest of systems [13].
In this study, we aim to identify specific alterations in functional
hypothalamic protein networks and the potential presentation of
keystone network factors that occur over time in the hypothala-
mus. In order to achieve this goal, we examined differences in
protein levels expressed in the hypothalami of young, middle-aged,
and old rats using a variety of synergistic combinatorial proteomic
and bioinformatic techniques. Following these unbiased mathe-
matical approaches, we show that specific protein networks that
are altered in the hypothalamus during the aging process may be
primarily linked to and regulated by a small number of crucial
‘network-crossing’ keystone factors. Investigating the nature of
these multidimensionally-active factors in the context of aging may
allow us to greatly enhance our understanding of the normal or
pathological aging process.
Results
Longitudinal hypothalamic protein expression patterns
Cytoplasmic hypothalamic extracts were prepared from young
(Y, 2–3 months), middle-aged (M, 10–12 months), and old (O, 24–
26 months) rats (n=8 each). Individual lysate samples were taken
from each animal and then pooled together for each age group.
One dimensional gel separation was performed to control for any
gross proteome differences between the three tissue pools (Fig. 1A).
Gel separation indicated that after coomassie staining the pool
inputs did not grossly differ in their global protein content. These
samples were then prepared for PanoramaH Cell Signaling
antibody array hybridization by labeling with Cy-3 or Cy-5
fluorescent dyes (Fig. 1B, C). Relative protein expression between
middle-aged (M) or old (O) versus young (Y) animals was assessed
(in triplicate) using standardized dye-swapping controls as de-
scribed previously [2]. Compared to young animals, there were 50
significantly differentially expressed proteins in middle aged
animals, demonstrating an M/Y expression ratio of .1.5
(p,0.05) and 55 proteins with an M/Y ratio of ,0.5 (p,0.05)
(Fig. 1D: Table S1). Considerably more proteins demonstrated
a significant change in expression between the old and the young
animal comparison: 118 proteins demonstrated an O/Y expres-
sion ratio of .1.5 (p,0.05) and 30 proteins possessed an O/Y
expression ratio of ,0.5 (p,0.05) (Fig. 1E: Table S2). We chose
six proteins identified in all the antibody array samples (demon-
strating up, down, or no change in expression regulation: Myc,
Akt, Pyk2, Map2, FAK, Cnp1) to validate the initial experiments
using standard western blot procedures (Fig. 1F–K). Using the
pooled hypothalamic samples (Y, M, O), we validated the
expression trends for each of these proteins (Myc, Pyk2, FAK:
up-regulated with advanced age; Akt, Map2: down-regulated with
advanced age; Cnp1: unchanged with advanced age) seen with the
Panorama
H Cell Signaling array analysis (Tables S1, S2). In
addition to standard western analysis of the input pooled
hypothalamic samples, we also performed validatory western
analysis on the individual animal samples (Fig. 1L–Q). Similarly to
the pooled samples, we observed the following significant protein
expression trends: Myc, Pyk2, FAK: up-regulated with advanced
age; Akt, Map2: down-regulated with advanced age; Cnp:
unchanged across age-span (Fig. 1L–Q).
With respect to the proteins differentially regulated between
middle-aged or old animals and the young cohort, 84 proteins
were found to be common between both M and O samples
(Fig. 2A). In the middle-aged hypothalami there were 22 uniquely-
regulated (not in O/Y) proteins (10 up-regulated, 12 down-
regulated), while in the old animals there were 64 uniquely-
regulated proteins (53 up-regulated, 11 down-regulated) (Fig. 2A).
Among the 84 proteins commonly regulated in M/Y and O/Y, 53
proteins were similarly regulated (compared to Y animals), with 38
proteins up-regulated in M and O (Fig. 2B, C) and 15 proteins
down-regulated in M and O (Figure 2D). We validated additional
proteins for each of these protein subgroups: caspase 3 (Casp3,
Fig. 2B), Ran (RAN, member RAS oncogene family, Fig. 2C) and
vinculin (Vcl, Fig. 2D). In each of these western validations we
recapitulated the expression trends observed with the antibody
array (Table S3).
Of the proteins identified in both M and O samples, when
compared to Y, there were 31 proteins differentially regulated
between M and O samples: three proteins were up-regulated in M
versus Y, yet down-regulated in O versus Y (Fig. 2E), and 28
proteins were down-regulated in M versus Y but up-regulated in O
versus Y (Fig. 2E). Again, we validated individual proteins for each
of these subgroups: junction plakoglobin (Jup, Fig. 2E) and nitric
oxide synthase-1 (Nos-1, Fig. 2E). In each of these western
validations we recapitulated the expression trends observed with
the antibody array.
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proteins
We performed two independent types of functional protein
clustering, KEGG signaling pathway analysis and GO term group
clustering, to assess the potential physiological focus of the
hypothalamic proteins altered with advancing age. Complete
significantly-regulated protein lists (Tables S1, S2), containing
proteins up- or down-regulated compared to Y animals, were used
for both forms of bioinformatic analysis. KEGG pathway or GO
term group clustering criteria were similar for both types of
analysis, i.e. .2 proteins per KEGG pathway/GO term group at
ap ,0.05 value (hypergeometric test of significance).
Clustering of the significantly-regulated hypothalamic proteins
from M or O animals resulted in the population of 44 and 56
distinct KEGG pathways, respectively (Tables S4, S5). There were
27 significantly-populated KEGG pathways that were common
between the two different age profiles (M/Y and O/Y) (Fig. 3A).
These commonly-populated KEGG pathways were then rationally
grouped together into sets focusing upon disease pathways
(Fig. 3B), neurophysiological architecture (Fig. 3C), and in-
termediary cell metabolism signaling pathways (Fig. 3D). Among
these commonly-regulated KEGG pathways, 22 out of 27
possessed a greater hybrid score (indicating the profundity of
KEGG pathway population) within the old animal datasets,
demonstrating a strong age-dependent trajectory of these pre-
dicted biological functions.
GO term group clustering of the significantly-regulated
hypothalamic proteins from M or O animals resulted in the
population of 112 and 114 distinct GO term group terms,
respectively (Tables S6, S7). There were 79 significantly-populated
GO terms common between the two different age profiles (M/Y
and O/Y) (Fig. S1A). Similar to the KEGG pathways, these GO
term groups were grouped together into rational functional sets:
cell structure/function (Fig. S1B), cell cycle control (Fig. S1C),
enzyme activity (Fig. S1D), and neurophysiological architecture
(Fig. S1E). Among these commonly-regulated GO term groups, 53
out of 79 possessed a greater hybrid score (indicating the
profundity of GO term group population) within the old animal
datasets, again demonstrating a strong age-dependent trajectory of
these functions.
The KEGG functional classifications created from the primary
hypothalamic protein data demonstrated the generation of
multiple neurodegenerative (‘Alzheimer’s disease’,‘ Huntington’s dis-
ease’,‘ Parkinson’s disease’), neurological (‘Prion diseases’,‘ Amyotrophic
lateral sclerosis’) and metabolic (‘Type II diabetes mellitus’) disorder-
related groups with advancing age (Fig. 3B). A profound age-
related cytoskeletal/focal adhesion remodeling functional pheno-
type (‘Focal adhesion’,‘ Axon guidance’,‘ Regulation of actin cytoskeleton’)
was also evident within the populated KEGG pathways (Fig. 3C).
Such functional predictions corroborate our previous western blot
and antibody array data, demonstrating a strong age-related
upregulation of proteins (Pyk2, FAK) involved in organizing
cytoskeletal dynamics in neuronal tissue (Fig. 1). Among the age-
related KEGG signaling pathway paradigms (Fig. 3D), several
convergent functional themes emerged: neurodevelopmental
signaling (‘TGF-beta signaling’,‘ Wnt signaling’), excitatory calcium
cell signaling (‘Phosphatidylinositol signaling’,‘ Calcium signaling’) and
metabolism-based signaling (‘VEGF signaling’,‘ Insulin signaling’,‘ Jak-
STAT signaling’) (Fig. 3D). Similar to the KEGG functional
analysis, the significantly-populated GO term group clusters also
revealed strong neuronal remodeling/focal adhesion/cytoskeletal
aspects (Fig. S1B, S1E), cell cycle regulation (Fig. S1C), and
calcium-targeted cell signaling enzyme activity (Fig. S1D) focused
functionalities.
Statistical clustering of proteins into different forms of canon-
ically-curated functional KEGG pathways or GO term groups
allows for a ‘higher-order’ appreciation of their functional
relationships to each other. However, many GO term groups,
and especially KEGG pathways, possess considerable vagueness,
content overlap, and experimental redundancy due to their
historically-curated nature [16]. While these functional annotation
tools may possess some drawbacks when their isolated use is relied
upon, it is likely that they can still be of great importance when
they are employed in a combinatorial manner with a novel form of
data-mining that has demonstrated great promise for discovering
previously unknown biomedical interactions, e.g. latent semantic
indexing [2,3,17–21]. Using latent semantic indexing (LSI) of
biomedical text databases, the mathematical correlations of input
text terms with genes/proteins can be assessed, even if they are not
present in classically curated datasets such as GO or KEGG. This
allows for the discovery of novel, previously unidentified connec-
tions between significantly altered genes/proteins.
Identification of multidimensional ‘keystone’ factors in
age-related protein networks
To identify novel protein factors that may act as keystones by
connecting the potentially complex series of functional networks
involved in aging, we performed combinatorial LSI using multiple
KEGG and GO term groups significantly populated by age-
regulated hypothalamic proteins. We chose twelve KEGG
signaling pathway text terms, including all functional subsets
described in Fig. 3B–D, to use as input interrogation terms for
a complete murine biomedical protein database (Computable
Genomix, https://computablegenomix.com/geneindexer). This
process yields lists of proteins that possess a quantitative LSI
correlation score (cut off of .0.1 indicates at least an ‘implicit’
Figure 1. Age-related proteomic alterations in the hypothalamus. (A) Coomassie staining of pooled input hypothalami for Cy-dye labeling
and hybridization with Cell Signaling antibody array: Y–young animal pool; M–middle-aged animal pool; O–old animal pool. (B) Prototypic single
channel and merge images from scanned PanoramaH Cell Signaling Antibody array chips. Specific antibody species are printed in duplicate across the
chip. (C) Prototypic examples of protein results for factors up-regulated, down-regulated, or unchanged in either Cy3 or Cy5 channels are indicated.
Positive and negative hybridization controls from the chips are also indicated. (D) Protein expression ratios (,0.5 or .1.5 ratio: middle versus young)
for proteins in middle aged versus young hypothalami. Datapoints plotted represent the mean 6 standard error of mean (SEM) from three separate
experimental hybridizations which included Cys-Cy5 dye swaps for the samples. (E) Protein expression ratios (,0.5 or .1.5 ratio: old versus young)
for proteins in old aged versus young hypothalami. Datapoints plotted represent the mean 6 SEM from three separate experimental hybridizations
which included Cys-Cy5 dye swaps for the samples. (F–K) Western blot validation of specifically identified proteins, from PanoramaH array analysis,
and their age-dependent expression trends (Y-young pool, M-middle aged pool, O-old pool). Proteins validated from pooled animal input were Myc
(F), Akt-1 (G), Pyk2 (H), Map2 (I), FAK (J), and Cnp-1 (K). Data presented represents mean 6 SEM from three separate blots. Statistical significance was
assessed using a Student’s t-test with GraphPad Prism: *=p,0.05; **=p,0.01; ***=p,0.001. (L–Q) Expression patterns for specific proteins were
also validated for each animal used as input for the Y (white circle), M (grey square), or O (black triangle) hypothalamic pools. Proteins validated from
individual animal inputs were Myc (L), Akt-1 (M), Pyk2 (N), Map2 (O), FAK (P) and Cnp-1 (Q). Data on the histograms are represented as mean 6 SEM
from the multiple animals.
doi:10.1371/journal.pone.0036975.g001
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equality between the output lists of LSI-correlating proteins from
the diverse input KEGG terms used (1-Regulation of actin
cytoskeleton, 2-Chemokine signaling, 3-Alzheimer’s disease, 4-
Focal adhesion, 5-MAPK signaling, 6-Gap junction, 7-GnRH
signaling, 8-Long term potentiation, 9-Notch signaling, 10-VEGF
signaling, 11-p53 signaling, 12-Calcium signaling), we chose the
top 1000 highest-scoring proteins in each case (terms 1–12). The
individual protein LSI correlation scores for the input KEGG
pathway terms (1–12) are listed in Tables S8, S9, S10, S11, S12,
S13, S14, S15, S16, S17, S18, S19. To identify potentially
multidimensional keystone factors in age-related protein patterns,
we combined the LSI correlation results from the 12 input KEGG
terms into a heatmap diagram. Only proteins that displayed an
LSI correlation (.0.1 score) in at least two separate KEGG term
outputs were used for heatmap analysis (Fig. 4A). Using a .2
KEGG pathway correlation cut-off, a matrix of 2524 proteins was
generated (Table S20). The highest number of correlations (8
KEGG terms) was achieved by 2 proteins: Grit (Rho GTPase
activating protein 32/Arhgap32) and GIT2 (G protein-coupled
receptor kinase interacting protein 2) (Fig. 4A: Table S20). The
mean LSI correlation scores for all correlated proteins, generated
by the twelve input terms, were all significantly greater than 0.1,
demonstrating a greater than implicit correlation for all proteins
(Fig. 4B). After taking together the total number of proteins
demonstrating multiple (.2) KEGG term correlations and
performing a group statistical analysis, twelve were found to exist
outside a 99% percentile of the mean results assuming a normal
distribution (10 with 7 correlations, 2 with 8 correlations) (Fig. 4C:
Box & Whiskers plot, p,0.001). These twelve proteins and their
specific KEGG term correlations are highlighted in Fig. 4D. GIT2
possessed a greater mean LSI correlation score (across the 8
KEGG pathways linked to it) than Grit, despite a similar number
of cross-KEGG pathway correlations (Fig. 4E). These unbiased
results may suggest that cytoskeletal-organizing factors could play
an important role in maintaining normal neuronal function with
age in the hypothalamus.
In addition to using KEGG pathway analysis for unbiased
keystone identification, we also employed GO term enrichment
analysis combined with LSI to investigate the presence of
multidimensional factors in hypothalamic aging. As with the
KEGG pathway term-directed LSI analysis, we chose twelve
significantly-populated GO terms from the four major functional
GO term groups (Fig. S1) and generated a correlation heatmap for
GO terms (Fig. S2A). As with the KEGG multidimensional
correlation analysis, we chose the top 1000 highest-scoring and
implicitly correlating proteins for each input GO term: 1-Actin
filament binding, 2-Anatomical structural development, 3-Cyclin-
dependent protein kinase inhibitor activity, 4-Regulation of cell
proliferation, 5-Cytoskeletal protein binding, 6-Macromolecular
complex, 7-Nitric oxide synthase activity, 8-Synapse, 9-Response
to stress, 10-Intracellular membrane-bound organelle, 11-Regula-
tion of programmed cell death, 12-Protein kinase activity
(Fig. S2B). The LSI protein output for each of these GO term
interrogation units are listed in Tables S21, S22, S23, S24, S25,
S26, S27, S28, S29, S30, S31, S32. As with the LSI analysis of the
input significant KEGG pathways, we employed a.2 cut-off for
the number of multiply-correlating proteins identified using GO
terminology input (Fig. S2C). Using this criterion, we created
a matrix containing 2902 proteins (Table S33). The highest
number of correlations presented by proteins was 7 and this was
achieved by 9 proteins: Ccdc88a–coiled-coil domain containing
88A, Kank1–KN motif and ankyrin repeat domains 1, Pcnp–
PEST proteolytic signal containing nuclear protein, Plekho1–
pleckstrin homology domain containing, family O member 1,
Rsu1–Ras suppressor protein 1, Tfpt–TCF3 (E2A) fusion partner,
GIT2–G protein-coupled receptor interacting transcript 2, Plrg1–
pleiotropic regulator 1, Zdhhc16–zinc finger, DHHC domain
containing 16 (Fig. S2A: Table S33). The mean LSI correlation
scores for all correlated proteins, generated by the twelve input
terms, were all significantly greater than 0.1, demonstrating
a greater than implicit correlation (Fig. S2B). After taking together
the total number of proteins demonstrating multiple (.2) GO
term correlations and performing a group statistical analysis, nine
were found (all with 7 correlations) to exist outside a 99%
percentile of the mean results assuming a normal distribution
(Fig. S2C: Box & Whiskers plot, p,0.001). These 9 proteins and
their specific GO term correlations are highlighted in Fig. S2D.
Among these highlighted multidimensional proteins, the mean LSI
correlation scores were relatively similar to each other (Fig. S2E).
Interestingly, the only protein that demonstrated a similar
presence in the most significantly correlating proteins from KEGG
and GO term LSI input was GIT2. We therefore chose to validate
the age-dependent changes predicted for GIT2, the highest
scoring and highest LSI-correlating protein, in the hypothalamus.
Age-dependent alterations in hypothalamic GIT2
expression
From our combinatorial bioinformatic investigation of predicted
age-dependent protein expression in the hypothalamus, we
decided to assess the age-dependent expression of GIT2 using
standardized techniques. We assessed protein expression with
specific western blots in three randomly-chosen young (Y1,Y 2,Y 3),
middle-aged (M1,M 2,M 3), and old rat hypothalami (O1,O 2,O 3:
Fig. 5A). We found that with similar levels of loaded protein
(10 mg), the ERK1/2 expression profile was unchanged with age
but the expression profile for Grit and GIT2 was strongly age-
dependent (Fig. 5A–B). The age-dependent elevation of GIT2 was
extremely profound while that of Grit was less strong. GIT2 often
demonstrates co-expression with a shorter isoform, termed GIT2-
Figure 2. Age-dependent protein expression changes in the rat hypothalamus. (A) Venn diagram analysis of significantly-regulated
(p,0.05) proteins in the middle versus young (grey circle) and the old versus young (black circle) antibody array analyses. Proteins uniquely regulated
in either middle age (22) or old age (64) animals are subsequently broken down into up-regulated (red numbers) or down-regulated (green numbers)
groups. The 84 commonly-regulated proteins were further dissected into different regulatory-behavior groups represented in panels B–E. For each
regulation-behavior group an exemplary protein is verified from the animal hypothalamic pools (Y–young, M–middle aged, O–old). (B) Proteins up-
regulated in both M (grey bars) and O (black bars) hypothalami compared to Y animals, with O ratio .M ratio. The associated validation was
performed using western blot for caspase 3 (Casp3). (C) Proteins up-regulated in both M (grey bars) and O (black bars) hypothalami compared to Y
animals, with M ratio .O ratio. The associated validation was performed using western blot for Ran. (D) Proteins down-regulated in both M (grey
bars) and O (black bars) hypothalami compared to Y animals, with M ratio .O ratio and O ratio .M ratio. The associated validation was performed
using western blot for vinculin (Vcl). (E) Proteins differentially regulated between M or O timepoints relative to Y (up-regulated at M and down-
regulated at O (verified using junction plakoglobin-Jup), or down-regulated at M and up-regulated at O (verified using nitric oxide synthase 1-Nos)).
For each verification, data on each histogram is represented as mean 6 SEM from the multiple animal pools. Statistical significance is as follows:
*=p,0.05, **=p,0.01, ***=p,0.001.
doi:10.1371/journal.pone.0036975.g002
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36975short (GIT2s). Similar to the age-dependent increase in GIT2
hypothalamic expression, we also found a strong elevation of
GIT2s with age (Fig. 5A). The GIT family of proteins consist of
GIT1 and GIT2, as well as the smaller isoforms of GIT2 including
GIT2s [22]. Proteins belonging to the GIT family were first
identified as ADP-ribosylation factor GTPase-activating proteins.
GIT proteins, and GIT1 especially, associate with signaling
factors, p21-activated kinase (PAK) and PAK-interacting ex-
change factor (PIX), and the monomeric G proteins that control
cytoskeletal remodeling, e.g. Rac and Cdc42, which regulate cell
structure and movement [22]. However, in contrast to GIT2 and
GIT2s, the levels of GIT1, b-PIX, or PAK1 did not demonstrate
a significant elevation with age in the hypothalamus (Fig. 5A–B),
suggesting a strong age-dependent hypothalamic functionality for
GIT2. As we have seen that protein expression of GIT2 is altered
during the aging process, we also investigated whether alterations
in post-translational modification of GIT2 are also sensitive to
aging. GIT2 functional activity has been demonstrated to be
associated with its tyrosine phosphorylation [23]. We assessed the
tyrosine phosphorylation status of GIT2 in normalized (for GIT2)
hypothalamic lysates collected from rats of the different ages. We
found a trend for age-dependent elevation of the phosphotyrosine
content in hypothalamic GIT2 (Fig. S3). This increase in
phosphotyrosine content may indeed be associated with the age-
related elevation in kinases linked to GIT2 phosphorylation such
as FAK (Fig. 1). We next assessed whether there were age-
dependent changes in GIT2 and GIT2s expression across other
regions of the central nervous system outside our primary
hypothalamic locus.
Age-dependent alterations in global brain GIT2
expression
Using identical levels of input protein (10 mg) we assessed the
age-dependent expression profile of GIT2 and GIT2s across
multiple brain regions in Y, M and O rats (Fig. 5C; relatively
quantified in Fig. 5D–GIT2, 5E–GIT2s). Using identical enzyme-
linked chemifluorescence exposure and phosophorimager data
collection parameters, we directly compared the age-dependent
expression profile of GIT2 and GIT2s in the brainstem,
cerebellum, cortex, hindbrain, hippocampus, hypothalamus,
pituitary, and striatum. Generally, the relative extent of GIT2 or
GIT2s expression increased with the advancing age of the rats. In
young animals, expression of GIT2 was almost undetectable in
many brain regions, e.g. the brainstem, cerebellum, and pituitary,
while in areas such as the cortex, hindbrain and especially the
hypothalamus, high expression of GIT2 was detected (Fig. 5C).
GIT2s demonstrated a generally similar expression profile to
GIT2 in the young animals across brain regions. Generally, there
was a progressive increase in GIT2 or GIT2s expression in the
middle and old-aged animals compared to the young animal
brain. Interestingly, in addition to the age-dependent alterations of
the long and short isoforms of GIT2 we also noted a prominent
‘intermediate’ GIT2-sera immunoreactive band of approximately
60–62 kDa that also demonstrates an age-dependent expression
alteration profile (Fig. S4). It is well known that multiple GIT2
splice forms exist, however the precise molecular structure of this
intermediate form remains an interesting topic for future studies
into its molecular activity. With respect specifically to the long
GIT2 isoform, progressive and significant increases in expression
(O..M..Y) were observed in the following regions: hypothal-
amus; brainstem; cerebellum; cortex; pituitary (Fig. 5D). In the
hindbrain, hippocampus and striatum GIT2 expression was
increased at the middle age time-point but then decreased with
advanced age (Fig. 5D). A qualitatively similar age- and tissue-
dependent expression profile was observed with GIT2s, with
respect to unidirectional increases in the hypothalamus, brainstem,
cerebellum, cortex, and pituitary as well as bimodal regulation in
the hindbrain, hippocampus, and striatum (Fig. 5E). As our
primary identification of the proteomic alterations in response to
aging were identified in the hypothalamus, we then compared the
age-dependent GIT2 and GIT2s expression changes in various
regions of the brain relative to this important core tissue (GIT2-
Fig. 5F–H; GIT2s-Fig. 5I–K). Relative to hypothalamic expres-
sion, there was a subtle difference between GIT2 and GIT2s
expression across the brain regions studied, i.e. hypothalamic
GIT2s expression was significantly higher than in all other brain
regions (Fig. 5I), while GIT2 expression was nearly identical
between the cortex and hypothalamus (Fig. 5F). In addition, there
was more tissue quantitative variation in GIT2 compared to
GIT2s when expression was measured relative to that in the
hypothalamus. In the middle-aged brain tissues, a greater
similarity of general GIT2 and GIT2s expression profiles were
detected (Fig. 5G, 5J). However, of specific note was the profound
relative elevation of pituitary expression levels of GIT2/GIT2s
compared to the hypothalamus. In addition to this, the relatively
strong expression of cortex and hindbrain GIT2 (relative to the
hypothalamus) in the young receded in the middle-aged animals
(Fig. 5G). When the oldest time point of GIT2/GIT2s expression,
relative to the hypothalamus, was assessed (Fig. 5H, 5K), the most
notable effect was again the successive -and statistically-significant-
overexpression of pituitary GIT2/GIT2s compared to the
hypothalamus. Therefore the two most consistent and profound
age-related changes in GIT2 and GIT2s expression occurred in
the pituitary and the hypothalamus. Both of these central nervous
system organs share a common functional axis; and hence this may
not be unexpected. In addition, both of these organs serve as
connective nodes between the central nervous system and the
peripheral endocrine systems that control major peripheral
biological systems such as reproduction and global energy
metabolism. We therefore next decided to investigate whether
these central nervous system tissue changes in GIT2/GIT2s
expression were mirrored in peripheral target organs linked to
energy metabolism.
Functional metabolic profile of aged animals
As the hypothalamus is closely associated with managing
energy-related systems in the brain and periphery, we first assessed
the circulating levels of hormones involved in energy metabolism
across the age-span of the rats. We noted a progressive increase in
body mass with age in the rats, however the majority of the
Figure 3. KEGG signaling pathway analysis of aging-related hypothalamic proteins. Proteins significantly regulated in middle (M) or old
(O) aged animals compared to young (Y) animals were used as input data for KEGG signaling pathway population analysis. (A) Venn diagram analysis
of middle-aged (grey line) and old-aged (black line) significantly-regulated KEGG pathways demonstrated 27 common KEGG terms between old and
middle-aged tissues. The common (27) significantly populated pathways for middle-aged (grey bars) and old aged (black bars) animals were then
rationally clustered into subgroups focused upon disease pathology (B), neurophysiological activity (C), and intermediary cellular signaling activity
(D). For each significantly-populated KEGG pathway a ‘hybrid’ score was generated which represents the 2log10 of the enrichment probability
multiplied with the relative enrichment factor compared to the background proteomic expression.
doi:10.1371/journal.pone.0036975.g003
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36975Figure 4. Latent semantic indexing correlations of KEGG signaling pathways terms with proteins. (A) Latent semantic indexing (LSI)
interrogation matrix between input significantly-regulated KEGG signaling pathway terms. Colored blocks represent the individual LSI implicit
correlation of the specific protein (vertically organized on left of heatmap: 1–2524 – see Table S20) with the respective KEGG term (1-Regulation of
actin cytoskeleton, 2-Chemokine signaling, 3-Alzheimer’s disease, 4-Focal adhesion, 5-MAPK signaling, 6-Gap junction, 7-GnRH signaling, 8-Long term
potentiation, 9-Notch signaling, 10-VEGF signaling, 11-p53 signaling, 12-Calcium signaling). The number of KEGG signaling pathway correlations for
each protein is indicated by the color of the respective heatmap blocks (9 correlations-red; 8 correlations-orange; 7 correlations-yellow; 6 correlations-
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and middle-aged time point (Fig. 6A). We noted a significant and
progressive increase in fasting glucose levels (Fig. 6B), fasting
insulin levels (Fig. 6C), and fasting leptin levels (Fig. 6D). As
expected, with the observed age-dependent increase in body mass,
we observed a significant age-dependent reduction in fasting
adiponectin levels (Fig. 6E). The age-span of the animals employed
in this study thus demonstrated a common pattern often observed
in humans across their lifetime, i.e., progressive weight gain and
potentially disrupted energy metabolism linked to insulin re-
sistance. When we assessed the age-dependent expression of GIT2
and GIT2s in tissues associated with a strong energy-metabolism
focus (pancreas, liver, skeletal muscle, and adipose tissue), we
found a similar age-dependent trend to that seen in the
hypothalamus. Strongly reminiscent of the age-dependent in-
creases of GIT2/GIT2s in the hypothalamus (Fig. 6F), we found
a progressive age-dependent increase of GIT2/GIT2s expression
in the pancreas (Fig. 6G), liver (Fig. 6H), skeletal muscle (Fig. 6I)
and adipose tissue (Fig. 6J). Therefore it seems that the progressive
alteration in GIT2 expression in the hypothalamus is mirrored in
multiple peripheral tissues associated with somatic energy metab-
olism.
Discussion
In this study, we examined alterations in protein signaling
networks in the hypothalamus of young, middle-aged, and old rats
in order to gain a better understanding of the functional alterations
that occur in the hypothalamus with aging. We have used novel
combinatorial bioinformatic techniques to identify potentially
pivotal factors that may control fundamental physiological pro-
cesses during the aging process, e.g. neuronal function and survival,
as well as somatic energy metabolism.
Using unbiased proteomic approaches, we identified a large
number of significant alterations in proteins in the hypothalamus
that link both neurological regulation and somatic metabolic status
(Fig. 1–2). Our protein-centered study complements previous data
generated from hypothalamic investigations. Jiang and colleagues
investigated the relationship between aging and gene expression in
the hypothalami and cortices of young and old BALB/c mice (2
and 22 months of age, respectively) using high-density oligonu-
cleotide arrays. In the hypothalamus from old mice, there was an
overall up-regulation of proteins involved in the mitochondrial
respiratory chain, neuronal structure, and protein processing
enzymes such as caspase-6 (Casp6: [24]). Caspase 6 belongs to
a family of cysteine proteases involved in neuronal apoptosis and
remodeling mechanisms [25,26]. Additionally, caspase-6 also
contributes to the processing of amyloid precursor protein and
the deposition of Alzheimer’s disease-related amyloid in the brain
[27]. In accordance with this earlier study, we also observed up-
regulation of Casp6 expression in the hypothalami of old rats
(Tables S1, S2). Additional caspases (Casp3, 7, 8, and 12) were
also found to be up-regulated in the aged rats. Expression of
caspase-2 and -3 has been found to be increased in the brains of
Alzheimer’s patients [28], strongly implicating a role for caspases
in age-related neurodegenerative disorders. In addition to
alterations in caspases, we found a strong cytoskeletally-linked
alteration in hypothalamic proteins, e.g. proline-rich tyrosine
kinase 2 (Pyk2) and focal adhesion kinase (FAK) (Fig. 1). Both of
these non-receptor tyrosine kinases are strongly associated with the
aging process and demonstrate expression changes in response to
protracted oxidative stress exposure as well as to excitoxicity, both
of which are highly characteristic facets of aging [29–33]. While
we observed a strong age-dependent elevation of both FAK and
Pyk2, interestingly we found a simultaneous decrease in another
protein associated with cytoskeletal function, the microtubule-
associated protein 2 (Map2) (Fig. 1). Stable neuronal Map2
expression has previously been demonstrated to be altered in the
aging process [34,35] as well as neurological disorders such as
Alzheimer’s disease [36,37] and Downs Syndrome [38]. It is
possible therefore that with reduced cellular integrity, e.g. with
Map2 reductions, an attempt to ameliorate this enhanced activity/
expression of focal adhesion kinases (Pyk2/FAK) is effected to
manage this. It is possible therefore that the expression profile of
many proteins may demonstrate a complex relationship to aging
or aging-related pathophysiologies, e.g. protein changes with time
may be causative or reactive in nature [5]. With respect to this, we
observed, similar to Map2, a significant age-related reduction in
cellular levels of the kinase v-akt murine thymoma viral oncogene
homolog 1 (Akt-1). This finding is similar to previous reports
associating altered Akt expression in the aging process [39–42].
This kinase typically forms a crucial role in cell survival pathways
associated with cell surface receptors, including G protein coupled
receptors and receptor tyrosine kinases systems such as the insulin/
insulin-like growth factor 1 (IGF-1) receptor [43–46]. However, as
with the diverse nature of protein expression responses to aging/
pathology, kinases such as Akt-1 are also associated with diverse
activity as they also help coordinate cell survival pathways and
apoptotic processes as well [47–49]. Therefore, our finding of
reduced Akt expression in the hypothalamus with aging may
represent both pathophysiological actions as well as reactive/
protective ones (Fig. 1). Akt-1 forms a vital component in signaling
pathways linked to somatic energy metabolism (e.g. insulin/IGF-1
receptor pathway); therefore it is also likely that this hypothalamic
expression alteration may also be connected to the alterations in
global metabolism seen in the aging rats (Fig. 6).
While significant alterations in individual proteins can generate
important information concerning the gestalt molecular activity
changes in a specific tissue with aging, the functional group
clustering of these proteins is more likely to yield physiologically-
relevant data. We performed two independent modes of unbiased
bioinformatic clustering of the proteins that were significantly
altered in the hypothalamus with increasing age. Firstly, we
demonstrated using KEGG signaling pathway clustering that age-
related proteomic changes in the hypothalamus were potentially
associated with neurodegenerative phenotypes (Alzheimer’s dis-
ease, Parkinson’s disease, Huntington’s disease), cognitive and
neurodevelopmental function (axon guidance, long-term potenti-
ation, Notch signaling, Wnt signaling pathway), dysglycemia (Type
II diabetes mellitus, insulin signaling), and neuronal cytoskeletal
remodeling (Focal adhesion, Gap junction, Regulation of actin
cytoskeleton) (Fig. 3). Using a parallel GO term-based clustering
process of the significantly-altered proteins detected in the aging
green; 5 correlations-light blue; 4 correlations-dark blue; 3 correlations-purple; 2 correlations-grey). (B) Mean 6 SEM for the total implicitly-correlating
proteins for each of the 12 input KEGG signaling pathways. (C) Box and whisker plot with 1–99% statistical cut-offs (GraphPad Prism) of the number of
specific correlations to KEGG pathways each protein possessed. Twelve proteins demonstrated a statistically-significantly greater number of KEGG
pathway correlations compared to the total protein mean number of correlations (***=p,0.001). (D) Expanded heatmap identification of specific
proteins possessing a significantly greater number of KEGG pathway correlations compared to the mean number of KEGG pathway correlations for all
implicit proteins. (E) Mean 6 SEM of LSI correlation scores (across all 9 correlations) for Grit and GIT2.
doi:10.1371/journal.pone.0036975.g004
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predictions. For example, GO term-based functional clustering
revealed significant enrichment of GO term groups associated with
regulation of subcellular organelle and protein complex regulation
(Macromolecular complex, intracellular membrane-bound organ-
elle), cellular homeostasis/stress responses (Regulation of cell
proliferation, Response to stress), cell signaling kinase cascade
activity (Cyclin-dependent protein kinase inhibitor activity, Nitric
oxide synthase activity), and neuronal cytoskeletal development
(Cytoskeletal protein binding, Synapse, Neuron projection)
(Fig. S1). Therefore, in both cases we found that a strong
concordance between KEGG and GO term analysis concerning
age-dependent alteration of pathways linked to neuronal remodel-
ing, cellular stress response and energy metabolism (from the
molecular level, e.g. kinase activity, up to the somatic level, e.g.
glucose regulation) was evident. As one of the initial goals of this
study was to generate mechanisms to identify potential keystone
protein factors that may integrate and control these multiple
synergistic activities occurring in the aging hypothalamus, we then
used a novel bioinformatic tool capable of revealing such factors,
i.e. latent semantic indexing (LSI). LSI specifically facilitates the
mathematical discovery of novel connections between distinct
input textual terms and genomic/proteomic factors. In this case
we employed a novel combinatorial approach to look for
convergence between multiple significantly-populated KEGG
and GO term groups with a whole-proteome protein reference
set. If indeed important keystone proteins linking energy
metabolism and neurophysiological regulation exist, it is likely
that they would possess a strong cross-correlation with multiple
KEGG or GO term groups generated by the direct significant
protein expression data. Using LSI heatmap matrix generation, we
were able to identify protein factors linked to the greatest numbers
of predicted functional aspects of the aging hypothalamic protein
network (Fig. 4; Fig. S2). When numerically ranking the proteins
that were predicted to possess the most number of functional
correlations with KEGG and GO terms, we found only one
protein common to both forms of analysis: GIT2. This protein
therefore could potentially possess multidimensional roles in
linking neuronal and energy-regulatory functions in the aging
process.
Our combinatorial informatics process allowed us to identify
a potentially important keystone factor for aging, without even its
initial detection in the antibody array screen. The antibody screen
is a standard platform that contains functionally important
signaling proteins that are evenly distributed between both
multiple GO and KEGG term annotations. Therefore, the array
provides a simple and transferrable platform for initial signaling
investigation of complex physiological events, e.g. aging. Using our
combinatorial informatics approach, we were able to expand the
initial hypothalamic protein signature to other functionally-related
proteins using a broad range of significantly-regulated KEGG or
GO pathways chosen to represent all of the diverse functionally-
predicted groups. In essence the phenotypic signature of the tissue,
created using the array platform, can be extended out to the
functional predictions (GO, KEGG and LSI) and subsequently
triangulated to discover factors that may possess strong convergent
roles in the specific biological process under study.
While a powerful tool, there are several mitigating limitations to
the employment of LSI in biological informatics. LSI-based
algorithms primarily attempt to uncover latent connections in text,
e.g. scientific abstracts. Therefore often there is a spectrum of
statistical strength in these uncovered connections, form the very
strong to the tenuous. In addition, the linkage process is purely
associative and does not include specific functional or regulatory
information. To compensate for these issues, we have firstly used
a multidimensional heatmap method, in which tenuous and
randomly-linked proteins are unlikely to rank as highly as proteins
with a recurrent association with multiple functional outputs
(Fig. 5). For this study a representative group of both KEGG
pathways and GO term groups were chosen to span all of the
functional paradigms generated using the informatic prediction
(Fig. 4, S1), without generating inordinately-large data streams for
analysis. It is highly likely that with increasing the number of
convergent LSI interrogation inputs, additional multidimensional
factors may be discovered. However it may be more efficient to
not force too much bias onto one LSI interrogation system, e.g.
KEGG pathways, but rather to use a multiplexed approach in
which several additional representative informatic outputs, e.g.
GO-terms, MeSH-terms, MGI-Mammalian Phenotype data, from
distinct bioinformatic sources are used for the discovery of
convergent proteins in physiological pathways. In addition to
these mainly technical considerations, it is always important to use
standard validation processes for expression analysis, of the LSI-
identified target factor. It is prudent, and physiologically impor-
tant, to investigate the expression of the target protein in multiple
tissues functionally related to the phenotypic profile under
investigation, e.g.‘ neurometabolic’ aging (Fig. 6). Such validation is
vital for discounting the potential for non-specific keystone factor
discovery from informatic workflows.
The GIT2 protein was originally identified as a factor associated
with connecting GPCRs to monomeric G proteins that control
cytoskeletal remodeling [50–52]. The ability to mediate efficient
neuronal remodeling is one of the most important factors in
controlling both short-term memory formation and maintaining
neural networks linked to both cognitive functions and stress-
response processes [19,53–58]. If GIT2 does indeed represent
a fundamental protein in the aging/energy regulation process,
then we may expect to identify age-related alterations of this factor
in multiple tissues involved in neural and endocrine/energy
regulatory networks. We found that in a wide variety of central
nervous system tissues (the hypothalamus, brainstem, cerebellum,
cortex, and pituitary), a strong unidirectional increase of GIT2
expression occurred with advancing age (Fig. 5). More complex,
bi-directional age-regulated changes in GIT2 expression were seen
in the hindbrain, striatum, and hippocampus (Fig. 5). The specific
reasons for these varied modes of GIT2 expression control may be
highly complex and will form the basis of future studies. In
addition to a strong age-dependent control of GIT2 expression in
the CNS, we also investigated whether GIT2 expression was
elevated in peripheral tissues linked with somatic energy metab-
Figure 5. Age-dependent expression profile of GIT2 in central nervous system tissues. (A) Expression profiles across three randomly
chosen hypothalamic samples (Young, Y1-Y2-Y3; Middle, M1-M2-M3; Old, O1-O2-O3) for ERK1/2, GRIT, GIT2, GIT2short (GIT2s), GIT1, b-PIX, and PAK1. The
loading protein input control with coomassie staining of the gel is also indicated below. (B) Quantification (mean 6 SEM) of age-dependent
alterations in protein expression for middle aged (grey bars) or old (black bars) animals compared to the young controls (white bars). (C) Brain region-
specific alterations of GIT2 and GIT2s in young (Y), middle (M), and old (O) age animals. Quantification of multi-brain region GIT2 (D) and GIT2s (E)
expression across the experimental age-span (n=10). Multiple brain region expression levels relative to hypothalamus of GIT2 in young (F), middle-
aged (G), and old animals (H). Multiple brain region expression levels, relative to hypothalamus of GIT2s in young (I), middle-aged (J), and old animals
(K). Statistical significance is as follows: *=p,0.05, **=p,0.01, ***=p,0.001.
doi:10.1371/journal.pone.0036975.g005
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muscle, and adipose tissue demonstrated a strong unidirectional,
age-dependent elevation of GIT2 and GIT2s expression, reminis-
cent of that observed in the hypothalamus (Fig. 6). These age-
dependent expression changes in GIT2 therefore could potentially
be associated with the gross endocrine hormonal age-dependent
changes that we observed in these animals, i.e. increasing
bodyweight, increasing fasting blood glucose, insulin, and leptin
levels, and decreasing adiponectin levels (Fig. 6). All of these
hormonal parameters are classically associated, in humans and
experimental animals, with advancing age and poor global
metabolic health [59–67]. The exact properties of GIT2 that
render it a potential keystone in the age-dependent modulation of
neuronal and metabolic functional networks remain to be
elucidated. It is likely that the role of GIT2 in these varied tissues
may be an evolutionarily-conserved mechanism that allows the
coherent integration of metabolic and sensory/cognitive functions.
Some of the first fundamental aging studies using simple
experimental organisms, such as C. elegans, strongly demonstrated
the vital role of coherent energy maintenance in controlling
longevity [68,69]. Many of these proteins that were first identified
to strongly control aging, e.g. insulin/insulin-like growth factor-1
receptor, Akt-1, and phosphatidylinositol 3-kinases (PI-3K), also
possess important neuroprotective actions (vital for healthy
neuronal aging) in both peripheral and central nervous tissue in
many species [70–73]. While these proteins linking metabolic and
neurological health were first identified in simple organisms like
the nematode, specific genetic ablation of components of this
family in adipose tissue, i.e. the fat-targeted insulin receptor
knockout, engenders an enhanced lifespan and stress resistance in
mice possessing this genotype [74]. Therefore, based upon our
evidence it is possible that GIT2 could also be associated with the
group of proteins linking energy metabolism with life/healthspan
regulation. This hypothesis will be investigated further in future
studies.
Our novel combinatorial bioinformatic approaches have
allowed us to analyze potentially crucial structural components
in relatively small hypothalamic protein networks that control age-
related neuronal and metabolic homeostasis. Based upon our
rigorous analyses, we show that endogenous physiological
responses to aging may be strongly orchestrated by the expression
level of the GIT2 protein. The relevance of the hypothalamic
expression level of this protein to the aging process in both
neuronal and energy-controlling tissues reinforces the importance
of this organ in the potential future development of targeted
pharmacotherapeutics designed to interdict a multitude of age-
related disorders.
Materials and Methods
Animal care and use
Male Sprague Dawley rats were used for this study: 2–3 month
old ‘young’ rats (n=8); 10–12 month old ‘middle’ aged rats (n=8);
24–26 month old ‘old’ rats (n=8). All animals were humanely
euthanized using isoflurane anesthesia, and the following tissues
were collected from each animal: hypothalamus, pituitary,
hippocampus, cortex, striatum, cerebellum, hindbrain, brain stem,
pancreas, liver, skeletal muscle, adipose tissue. All animal testing
procedures were approved by the Animal Care and Use
Committee of the National Institute on Aging (NIA) under NIA
protocol number 293-LNS-2011. Tissues were snap frozen at
280uC following dissection. Additionally, approximately 2 mL of
blood was collected from each animal into tubes coated with
EDTA. Isolated hypothalami, pancreata, liver, hind-limb skeletal
muscle, and subcutaneous fat from each rat were individually
fractionated into four major subcellular compartments (cytoplas-
mic, plasma membrane, large organelles (e.g. mitochondria and the
actin cytoskeleton) using a Q-proteome tissue fractionation kit
according to the manufacturer’s instructions (Qiagen Corporation,
Valencia, CA). The protein concentrations for all four subcellular
fractions of the hypothalami were then normalized to at least
0.5 mg/mL using a BCA protein estimation protocol according to
manufacturer’s instructions (ThermoScientific, Rockford, IL).
Cell signaling antibody microarray
Preparation of protein samples, Cy3/Cy5 dye labeling (GE
Healthcare, Waltham, MA), application to the Panorama
H Cell
Signaling Array chip, and data analysis were performed as
previously described [2] according to the manufacturer’s instruc-
tions using the proprietary solutions and equipment provided in
the kit (Sigma, St. Louis, MO). Individually-extracted cytoplasmic
samples from the rats were equally pooled into three categories
according to age: young (Y), middle-aged (M), and old (O).
Panorama chips were performed in triplicate for the following
direct comparisons: middle (M) vs. young (Y); old (O) vs. young
(Y). Label swaps for the dye-sample combinations were made and
the whole series of experiments repeated again (n=3). The
differential fluorescent signal intensity for each antibody spot was
recorded using a multimodal phosphorimager scanning at a 10mm
spot pattern (Typhoon 9410, GE Healthcare, Piscataway, NJ). In
order to be considered for further analysis, the recorded expression
ratios (estimated through Cy3:Cy5 fluorescence ratios) between M
vs. Y or O vs. Y had to be significantly different (greater than or
less than) from unity (p,0.05, non-paired Student’s t-test:
GraphPad Prism version 5.0, San Diego, CA). Validations of
randomly selected up-regulated and down-regulated proteins
identified by the microspotted antibodies were performed using
Figure 6. Correlation of GIT2 and GIT2s expression with metabolic phenotype changes in aging rats. (A) Age-dependent changes in
mean body weight for the multiple age ranges of rats. (B) Fasting blood glucose measurements for the multiple age ranges of rats. (C) Fasting plasma
insulin measurements for the multiple age ranges of rats. (D) Fasting plasma leptin measurements for the multiple age ranges of rats. (E) Fasting
plasma adiponectin measurements for the multiple age ranges of rats. (F) GIT2 and GIT2s age-dependent expression in young (Y), middle-aged (M),
and old rat hypothalamic extracts. The associated histograms depict the mean 6 SEM of the GIT2 and GIT2s expression in middle-aged (grey bars)
and old (black bars) animals relative to the young (white bars) samples. (G) GIT2 and GIT2s age-dependent expression in young (Y), middle-aged (M),
and old rat whole pancreatic extracts. The associated histograms depict the mean 6 SEM of the GIT2 and GIT2s expression in middle-aged (grey bars)
and old (black bars) animals relative to the young (white bars) samples. (H) GIT2 and GIT2s age-dependent expression in young (Y), middle-aged (M),
and old rat whole liver extracts. The associated histograms depict the mean 6 SEM of the GIT2 and GIT2s expression in middle-aged (grey bars) and
old (black bars) animals relative to the young (white bars) samples. (I) GIT2 and GIT2s age-dependent expression in young (Y), middle-aged (M), and
old rat hind-limb skeletal muscle extracts. The associated histograms depict the mean 6 SEM of the GIT2 and GIT2s expression in middle-aged (grey
bars) and old (black bars) animals relative to the young (white bars) samples. (J) GIT2 and GIT2s age-dependent expression in young (Y), middle-aged
(M), and old rat somatic adipose tissue extracts. The associated histograms depict the mean 6 SEM of the GIT2 and GIT2s expression in middle-aged
(grey bars) and old (black bars) animals relative to the young (white bars) samples. Statistical significance is as follows: *=p,0.05, **=p,0.01,
***=p,0.001.
doi:10.1371/journal.pone.0036975.g006
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Western blotting procedures
Specific proteins were resolved using one-dimensional gel
electrophoresis. Hypothalamic cytoplasmic extracts (containing
15 mg of total protein) were run on 4–12% Bis-Tris poly-
acrylamide gels (Invitrogen, Carlsbad, CA) before electrotransfer
to a polyvinylenedifluoride (PVDF) membrane (NEN Life
Sciences, Boston, MA). PVDF membranes were blocked for one
hour at room temperature in 4% non-fat milk (Santa Cruz
Biotechnology, Santa Cruz, CA) before blotting. Specific antisera
employed were obtained from the following sources: proline-rich
tyrosine kinase 2 (Pyk2), G protein-coupled receptor kinase
interacting protein 2-short form (GIT2s), focal adhesion kinase
(FAK), G protein-coupled receptor kinase interacting protein 1
(GIT1) (BD Biosciences, San Jose, CA); myc, microtubule-
associated protein 2 (Map2), Ran/TC4, vinculin (Vcl), nitric
oxide synthase-1 (Nos1) (Santa Cruz Biotechnology, Santa Cruz,
CA); Akt, caspase 3, extracellular signal-regulated kinase 1/2
(ERK1/2), p21 protein (Cdc42/Rac)-activated kinase 1 (PAK1),
Rho guanine nucleotide exchange factor (GEF) 7 (b-PIX) (Cell
Signaling Technology, Danvers, MA); junction plakoglobin (Jup)
(Sigma Aldrich, St. Louis, MO); G protein-coupled receptor kinase
interacting protein 2 (GIT2) (NeuroMab, San Jose, CA); 29,39-
cyclic nucleotide 39 phosphodiesterase (Cnp1) (Abnova, Walnut,
CA). Detection of primary immune complexes were performed
with subsequent application of a 1:10,000 dilution of an alkaline
phosphatase-conjugated, species-specific secondary antibody (Sig-
ma Aldrich, St. Louis, MO) followed by enzyme-linked chemi-
fluorescence exposure (GE Healthcare, Pittsburgh, PA) and digital
quantification using a Typhoon 9410 phosphorimager with
ImageQuant 5.2 L software (GE Healthcare, Pittsburgh, PA).
Standard Coomassie staining methods were used to ensure equal
protein concentrations of the SDS-PAGE gel. Gels were fixed for
30 minutes by immersion in 10% v/v glacial acetic and 30% v/v
methanol. G250 Coomassie was then added for a one hour
incubation period with agitation. After staining, the gel was
washed in destaining solution containing 3% glacial acetic acid
until the stain background was adequately removed. For GIT2
immunoprecipitation experiments, GIT2 antisera were employed
(NeuroMab, San Jose, CA) with overnight incubation at 4uC
before addition of 30 mL of Protein G Plus/Protein A Agarose
(EMD Biosciences) for 1 hour and subsequent collection of GIT2
immunoprecipitates with low-speed centrifugation. Phosphotyro-
sine content of gel-resolved proteins was assessed using a 1:1,000
dilution of anti-phosphotyrosine PY20 (Santa Cruz Biotechnology,
CA) sera.
Bioinformatics Analyses
Protein sets generated from the antibody microarray were
analyzed using WebGestalt (http://bioinfo.vanderbilt.edu/
webgestalt/). Significant clustering of proteins into GO (gene
ontology) terms and KEGG (Kyoto encyclopedia of genes and
genomes) pathway groups was performed using a hypergeometric
test of significance (p,0.05). At least two independent proteins
were required for significant population of specific GO groups or
KEGG pathways. The relative profundity of the GO term or
KEGG pathway population was measured as described previously
using a ‘hybrid score’ approach [2]. Briefly, hybrid scores for GO
term groups or KEGG pathways were calculated by multiplication
of the negative log10 of the enrichment probability (P) with the
enrichment ratio (R). Latent semantic indexing (LSI) bioinformatic
analyses were performed using GeneIndexer (Computable Geno-
mix LLC, https://computablegenomix.com/geneindexer) as de-
scribed previously [2,3].
Plasma hormone analysis
Approximately 2 mL of blood was collected from each animal
into Vacutainer
TM tubes coated with EDTA (BD Biosciences, San
Jose, CA). Blood glucose concentration was measured as pre-
viously described [75]. Samples were centrifuged (3000 rpm,
30 minutes, 4uC) and plasma from each tube was collected and
then stored at 280uC until used. When required, samples were
thawed overnight at 4uC prior to analysis. The plasma levels of
specific metabolic hormones were measured using enzyme-linked
immunosorbent assays (ELISA) (Millipore, Billerica, MA). The
hormones measured were insulin, leptin, and adiponectin. Each
sample was run in duplicate on a 96-well plate. Analysis of quality
control standards provided in the kits met expectations, validating
the accuracy of the panels.
Supporting Information
Figure S1 Gene Ontology term analysis of aging-related
hypothalamic proteins. Proteins significantly regulated in
middle (M) or old (O) aged animals compared to young (Y)
animals were used as input data for Gene Ontology (GO) term
population analysis. (A) Venn diagram analysis of middle-aged
(grey line) and old-aged (black line) significantly-regulated GO
term groups demonstrated 79 common GO terms between old
and middle-aged tissues. The common (79) significantly populated
pathways for middle-aged (grey bars) or old aged (black bars)
animals were then rationally clustered into subgroups focused
upon cell structure/function (B), cell cycle regulation (C), enzyme
activity (D), and neurophysiological architecture (E). For each
significantly-populated GO term group a ‘hybrid’ score was
generated which represents the 2log10 of the enrichment
probability multiplied with the relative enrichment factor
compared to the background proteomic expression.
(TIF)
Figure S2 Latent semantic indexing (LSI) correlations of
Gene Ontology groups with proteins. (A) Latent semantic
indexing (LSI) interrogation matrix between input significantly-
regulated Gene Ontology (GO) term groups. Colored blocks
represent the individual LSI implicit correlation of the specific
protein (vertically organized on left of heatmap: 1–2524 – see
Table S20) with the respective GO term (1-Actin filament binding,
2-Anatomical structural development, 3-Cyclin-dependent protein
kinase inhibitor activity, 4-Regulation of cell proliferation, 5-
Cytoskeletal protein binding, 6-Macromolecular complex, 7-Nitric
oxide synthase activity, 8-Synapse, 9-Response to stress, 10-
Intracellular membrane-bound organelle, 11-Regulation of pro-
grammed cell death, 12-Protein kinase activity). The number of
KEGG signaling pathway correlations for each protein is indicated
by the color of the respective heatmap blocks (7 correlations-
yellow; 6 correlations-green; 5 correlations-light blue; 4 correla-
tions-dark blue; 3 correlations-purple; 2 correlations-grey). (B)
Mean 6 SEM for the total implicitly-correlating proteins for each
of the 12 input GO term groups. (C) Box and whisker plot with 1–
99% statistical cut-offs (GraphPad Prism) of the number of specific
correlations to GO term groups each protein possessed. Twelve
proteins demonstrated a statistically-significantly greater number
of GO term group correlations compared to the total protein
mean number of correlations (***=p,0.001). (D) Expanded
heatmap identification of specific proteins possessing a significantly
greater number of GO term group correlations compared to the
mean number of GO term group correlations for all implicit
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correlations) for Ccdc88a, Kank1, Pcnp, Plekho1, Rsu1, Tfpt,
GIT2, Plrg1, and Zdhhc16.
(TIF)
Figure S3 Age-dependent alteration in GIT2 phospho-
tyrosine content. Anti-GIT2 immunoprecipitates were per-
formed on hypothalamic lysates from young (Y), middle-aged (M)
or old (O) rats. The immunoprecipitates were then assessed for
GIT2 content using western blot, and then based upon this
normalized for a subsequent western that ensured equal GIT2
loading from the specific immunoprecipitate. This western blot
was then probed with a generic anti-phosphotyrosine anti-sera
(anti-P-Tyr). The associated histogram indicates GIT2 phospho-
tyrosine content. Data represented as mean 6 SEM, n=3,
*=p,0.05).
(TIF)
Figure S4 Age-dependent alteration in the expression of
an ‘intermediate’ mass GIT2 isoform. (A) Using specific
anti-GIT2 sera, the primary species observed in the hypothalamus
and other central nervous system regions were 85 kDA (1.) and
55 kDa (3.). A prominent intermediate mass GIT2 immunoreac-
tive species was also observed and was estimated to be 60–62 kDa
(2.). (B) Age-dependent expression variation of the intermediate
mass (60–62kDa) GIT2 immunoreactive species across multiple
regions of the central nervous system. Expression profile, relative
to that in the hypothalamus, of the intermediate (60–62kDa) GIT2
immunoreactive isoform in young (C), middle-aged (D) and old (E)
rats. Anti-GIT2 immunoprecipitates were performed on hypotha-
lamic lysates from young (Y), middle-aged (M) or old (O) rats. The
histograms depict intermediate GIT2 immunoreactive form
expression. Data represented as mean 6 SEM, n=3,
*=p,0.05, **=p,0.01, ***=p,0.001.
(TIF)
Table S1 Protein expression alterations in middle-aged
compared to young rat hypothalamus. PanoramaH Cell
Signaling Array platforms were employed to assess the relative
expression ratio of individual proteins for middle-aged (M) versus
young (Y) rats (M/Y). Expression ratios were calculated from
triplicate experiments and the mean and standard error of the
mean (SEM) for each protein demonstrating an M/Y ratio using
the following criteria: ratio.1.5 and ratio,0.5.
(DOC)
Table S2 Protein expression alterations in old com-
pared to young rat hypothalamus. PanoramaH Cell
Signaling Array platforms were employed to assess the relative
expression ratio of individual proteins for old (O) versus young (Y)
rats (O/Y). Expression ratios were calculated from triplicate
experiments and the mean and standard error of the mean (SEM)
for each protein demonstrating an O/Y ratio using the following
criteria: ratio.1.5 and ratio,0.5.
(DOC)
Table S3 Proteins significantly regulated in both mid-
dle- and old-aged rat hypothalami compared to young
rats. PanoramaH Cell Signaling Array platforms were employed
to assess the relative expression ratio of individual proteins for
middle-aged/old (M or O) versus young (Y) rats (M/Y or O/Y).
Expression ratios were calculated from triplicate experiments and
the mean and standard error of the mean (SEM) for each protein
demonstrating an O/Y ratio using the following criteria: ratio.1.5
and ratio,0.5.
(DOC)
Table S4 KEGG signaling pathway enrichment for
middle-aged versus young rat protein expression vari-
ation. KEGG signaling pathway enrichment was performed
using WebGestalt with the protein set significantly altered in
middle aged hypothalami compared to the young controls. KEGG
signaling pathway text description, enrichment factor (R),
probability of enrichment (P), and the resultant hybrid score (H:
2log10(P)6R) is represented.
(DOC)
Table S5 KEGG signaling pathway enrichment for old
versus young rat protein expression variation. KEGG
signaling pathway enrichment was performed using WebGestalt
with the protein set significantly altered in old-aged hypothalami
compared to the young controls. KEGG signaling pathway text
description, enrichment factor (R), probability of enrichment (P),
and the resultant hybrid score (H: 2log10(P)6R) is represented.
(DOC)
Table S6 GO-term enrichment for middle versus young
rat protein expression variation. GO-term enrichment was
performed using WebGestalt with the protein set significantly
altered in middle aged hypothalami compared to the young
controls. Official GO-term codes, the text description of the code
as well as the enrichment factor (R), probability of enrichment (P),
and the resultant hybrid score (H: 2log10(P)6R) is represented.
(DOC)
Table S7 GO-term enrichment for old versus young
protein expression variation. GO-term enrichment was
performed using WebGestalt with the protein set significantly
altered in middle aged hypothalami compared to the young
controls. Official GO-term codes, the text description of the code
as well as the enrichment factor (R ), probability of enrichment (P),
and the resultant hybrid score (H: 2log10(P)6R) is represented.
(DOC)
Table S8 GeneIndexer latent semantic indexing (LSI) of
significantly-regulated ‘Regulation of actin cytoskeleton’
KEGG pathway. Using the KEGG signaling pathway ‘Regula-
tion of actin cytoskeleton’ as an input term, a list of the top 1000
implicitly-correlated (LSI correlation score .0.1) was generated
using a full genome background list.
(DOC)
Table S9 GeneIndexer latent semantic indexing (LSI) of
significantly-regulated ‘Chemokine signaling’ KEGG
pathway. Using the KEGG signaling pathway ‘Chemokine
signaling’ as an input term, a list of the top 1000 implicitly-
correlated (LSI correlation score .0.1) was generated using a full
genome background list.
(DOC)
Table S10 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Alzheimer’s disease’ KEGG
pathway. Using the KEGG signaling pathway ‘Alzheimer’s
disease’ as an input term, a list of the top 1000 implicitly-
correlated (LSI correlation score .0.1) was generated using a full
genome background list.
(DOC)
Table S11 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Focal adhesion’ KEGG path-
way. Using the KEGG signaling pathway ‘Focal adhesion’ as an
input term, a list of the top 1000 implicitly-correlated LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
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of significantly-regulated ‘MAPK signaling’ KEGG path-
way. Using the KEGG signaling pathway ‘MAPK signaling’ as an
input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S13 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Gap junction’ KEGG path-
way. Using the KEGG signaling pathway ‘Gap junction’ as an
input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S14 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘GnRH signaling’ KEGG path-
way. Using the KEGG signaling pathway ‘GnRH signaling’ as an
input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S15 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Long term potentiation’
KEGG pathway. Using the KEGG signaling pathway ‘Long
term potentiation’ as an input term, a list of the top 1000
implicitly-correlated (LSI correlation score .0.1) was generated
using a full genome background list.
(DOC)
Table S16 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Notch signaling’ KEGG path-
way. Using the KEGG signaling pathway ‘Notch signaling’ as an
input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S17 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘VEGF signaling’ KEGG path-
way. Using the KEGG signaling pathway ‘VEGF signaling’ as an
input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S18 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘p53 signaling’ KEGG path-
way. Using the KEGG signaling pathway ‘p53 signaling’ as an
input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S19 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Calcium signaling’ KEGG
pathway. Using the KEGG signaling pathway ‘Calcium
signaling’ as an input term, a list of the top 1000 implicitly-
correlated (LSI correlation score .0.1) was generated using a full
genome background list.
(DOC)
Table S20 GeneIndexer latent semantic indexing (LSI)
correlation matrix for twelve input KEGG signaling
pathway terms. The input text terms are numerated as follows:
1-Regulation of actin cytoskeleton,2 - Chemokine signaling,3 - Alzheimer’s
disease,4 - Focal adhesion,5 - MAPK signaling,6 - Gap junction,7 - GnRH
signaling,8 - Long term potentiation,9 - Notch signaling, 10-VEGF signaling,
11-p53 signaling, 12-Calcium signaling. An implicit correlation (LSI
score .0.1) of the specific protein and the respective input KEGG
terms is denoted by a 1. When no correlation occurs, a 0 is
present.
(DOC)
Table S21 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Actin filament binding’ GO
term group. Using the GO term group ‘Actin filament binding’
as an input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S22 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Anatomical structural devel-
opment’ GO term group. Using the GO term group
‘Anatomical structural development’ as an input term, a list of
the top 1000 implicitly-correlated (LSI correlation score .0.1) was
generated using a full genome background list.
(DOC)
Table S23 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Cyclin-dependent protein ki-
nase inhibitor activity’ GO term group. Using the GO term
group ‘Cyclin-dependent protein kinase inhibitor activity’ as an
input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S24 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Regulation of cell prolifera-
tion’ GO term group. Using the GO term group ‘Regulation of
cell proliferation’ as an input term, a list of the top 1000 implicitly-
correlated (LSI correlation score .0.1) was generated using a full
genome background list.
(DOC)
Table S25 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Cytoskeletal protein binding’
GO term group. Using the GO term group ‘Cytoskeletal
protein binding’ as an input term, a list of the top 1000 implicitly-
correlated (LSI correlation score .0.1) was generated using a full
genome background list.
(DOC)
Table S26 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Macromolecular complex’
GO term group. Using the GO term group ‘Macromolecular
complex’ as an input term, a list of the top 1000 implicitly-
correlated (LSI correlation score .0.1) was generated using a full
genome background list.
(DOC)
Table S27 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Nitric oxide synthase activity’
GO term group. Using the GO term group ‘Nitric oxide
synthase activity’ as an input term, a list of the top 1000 implicitly-
correlated (LSI correlation score .0.1) was generated using a full
genome background list.
(DOC)
Table S28 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Synapse’ GO term group.
Using the GO term group ‘Synapse’ as an input term, a list of
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PLoS ONE | www.plosone.org 17 May 2012 | Volume 7 | Issue 5 | e36975the top 1000 implicitly-correlated (LSI correlation score .0.1) was
generated using a full genome background list.
(DOC)
Table S29 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Response to stress’ GO term
group. Using the GO term group ‘Response to stress’ as an input
term, a list of the top 1000 implicitly-correlated (LSI correlation
score .0.1) was generated using a full genome background list.
(DOC)
Table S30 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Intracellular membrane-
bound organelle’ GO term group. Using the GO term
group ‘Intracellular membrane-bound organelle’ as an input term,
a list of the top 1000 implicitly-correlated (LSI correlation score
.0.1) was generated using a full genome background list.
(DOC)
Table S31 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Regulation of programmed
cell death’ GO term group. Using the GO term group
‘Regulation of programmed cell death’ as an input term, a list of
the top 1000 implicitly-correlated (LSI correlation score .0.1) was
generated using a full genome background list.
(DOC)
Table S32 GeneIndexer latent semantic indexing (LSI)
of significantly-regulated ‘Protein kinase activity’ GO
term group. Using the GO term group ‘Protein kinase activity’
as an input term, a list of the top 1000 implicitly-correlated (LSI
correlation score .0.1) was generated using a full genome
background list.
(DOC)
Table S33 GeneIndexer latent semantic indexing (LSI)
correlation matrix for twelve input GO term groups. The
input text terms are numerated as follows: 1-Actin filament binding,2 -
Anatomical structural development,3 - Cyclin-dependent protein kinase inhibitor
activity,4 - Regulation of cell proliferation,5 - Cytoskeletal protein binding,6 -
Macromolecular complex,7 - Nitric oxide synthase activity,8 - Synapse,9 -
Response to stress, 10-Intracellular membrane-bound organelle, 11-Regulation
of programmed cell death, 12-Protein kinase activity. An implicit
correlation (LSI score .0.1) of the specific protein and the
respective input KEGG terms is denoted by a 1. When no
correlation occurs, a 0 is present.
(DOC)
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